Fisher says his firm is not among the largest shareholders of French pharmaceutical company Sanofi, as the Times' reports. The company makes up less than 0.8% of Fisher's portfolio.
The FPA, IAA, CFP Board and others are asking Congress to reinstate the tax deduction, which was repealed in the 2017 tax law, as well as expand the number of taxpayers who could benefit from it.
